Navigation Links
Maxam Nutraceutics Introduces PCA-Rx as a Natural Chelation Alternative for Autism Spectrum Disorder Treatment
Date:5/27/2010

HOOD RIVER, Ore., May 27 /PRNewswire/ -- According to the Center for Disease Control (CDC), autism has risen to an epidemic rate of 1 in 100 in the U.S., up from 1 in 150 in 2007. While controversy looms regarding its cause, many parents of autistic children believe a correlation exists with toxin accumulation. To give autism spectrum disorder (ASD) sufferers a natural alternative to chelation therapy, Maxam Nutraceutics (www.maxamlabs.com) has introduced PCA-Rx.

While chelation is commonly administered intravenously using the drug agents dimercaptosuccine acid (DMSA) and dimercaptopropane sulfonate (DMPS), this heavy metal removal method has come increasingly under fire by parents concerned about side effects.

Tina Beeck, who switched from chelation to PCA-Rx for treating her 4-year-old autistic son, Miller, stated, "We have been extremely pleased with PCA-Rx. We have seen tremendous cognitive gains – slowly at first and then dramatically. Sometimes he seems downright neuro-typical."

The result of years of rigorous research and development, PCA-Rx represents a breakthrough in toxin removal technology called Clathration Therapy. PCA-Rx is an epigenetic cell fermentation formula comprised of helpful bacteria and other microbes that, when used, become a natural, living part of the body's immune system. Administered orally, one to eight sprays per day under the tongue, it envelops, neutralizes and removes the harmful toxins through stool, urine, skin and breath, without ever touching vital organs or tissue.

PCA-Rx helps to eliminate heavy metals, chemical toxins and harmful parasite microorganisms; reduce cardio and cerebral vascular plaque; lower elevated enzyme counts; and decrease environmental illness effects.

"PCA-Rx represents the next generation of chelation technology," explained Maxam Nutraceutics President James Cole. "We're thrilled to provide autism sufferers a natural toxin removal treatment that's easy-to-use, powerful and with no known side effects."

PCA Rx is also used for Alzheimer's, candida, cervical dystonia, chemical exposure, heart disease, hepatitis, herpes, Lyme disease, paralysis, Niemann-Pick disease and uterine fibroids. It is available through www.maxamlabs.com.

For more information, or interview scheduling with James Cole, contact Renee Cooper, ChristieCommunications(www.christiecomm.com) or (805)969-3744, rcooper@christiecomm.com.

*PCA Rx has not been evaluated by the FDA and not intended to diagnose, treat, or cure any disease.


'/>"/>
SOURCE Maxam
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bioenergy Introduces Corvalen M(R) as a Natural Treatment Option for Fibromyalgia Symptoms
2. Bersin & Associates Introduces New Talent Management Framework
3. Varian Medical Systems Introduces ProBeam(TM) Proton Therapy Platform at Particle Therapy Co-operative Group (PT COG) 2010 Meeting
4. Ambry Genetics Introduces AmbryScreen(TM), a Genetic Test Screening for Some of the Most Common and Severe Genetic Disorders Affecting Newborns.
5. Ethicon Endo-Surgery Introduces Two New Staplers for Open Surgical Procedures at ASCRS
6. Biosense Webster Introduces the THERMOCOOL(R) SF Irrigated Catheter in the European Union
7. Ethicon Endo-Surgery Introduces HARMONIC FOCUS(R) Long Curved Shears for Deep Surgical Access
8. MAQUET Cardiovascular Introduces New VASOSHIELD Pressure Controlling Syringe to Help Preserve Graft Integrity for Coronary Artery Bypass Surgery Patients
9. Burton Medical Introduces the AIM-200(R) as a Versatile, Long-Lasting Light Source for Ambulatory Surgical Centers
10. Sikorsky Global Helicopters Introduces State-of-the-Art Emergency Medical Services Interior for S-76(R) Helicopter
11. Samplify Introduces New Compression Technology to Lower Costs for Mobile Operators Migrating to 4G
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... Research and Markets has ... Ischemic Stroke Market and Competitive Landscape Highlights ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) ... Market and Competitive Landscape Highlights 2016, provides ... products, Acute Ischemic Stroke epidemiology, Acute Ischemic ...
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Actinic Keratosis Market ... to their offering.       (Logo: ... Keratosis Market and Competitive Landscape Highlights 2016, ... products, Actinic Keratosis epidemiology, Actinic Keratosis market ...
(Date:5/3/2016)... 4, 2016 Global Insulin ... profiling 09 key companies and supported with 272 ... in-depth study on the current state of the ... the industry including definitions, classifications, applications and industry ... provided for the international market including development history, ...
Breaking Medicine Technology:
(Date:5/5/2016)... ... 2016 , ... Spring Fertility , the only fertility ... egg freezing, today announced the grand opening of its first location in San ... Fertility offers both fertility preservation (egg, sperm, embryo, and testicular and ovarian tissue ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... Wharton Seminars for Business Journalists , led by the Wharton School’s ... and economic issues.  This one-day program at the Wharton School’s San Francisco ...
(Date:5/5/2016)... ... May 05, 2016 , ... United Benefit Advisors (UBA), ... as the latest addition to its family of Partner Firms. Headquartered in Mount ... wellness, human resources, and health care consumerism specialists. , “Partnering with UBA will ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... Make-A-Wish grants the most heartfelt wishes of these children. The wishes provide ... treatment. President and CEO of Make-A-Wish Mississippi, Brent Wilson said, “In 2016, ...
(Date:5/5/2016)... ... May 05, 2016 , ... Michael Lanteri Agency ... created to assist the people of their local community. The agency pledges to ... community leaders. Their hope is to bring awareness to important local causes with ...
Breaking Medicine News(10 mins):